RETRACTED ARTICLE: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2
Authors:
Open Access
- 29 May 2020
- journal article
- retracted article
- Published by Springer Nature in Cancer Cell International
- Vol. 20 (1) , 1-15
Abstract
Background: To explore the expression pattern and role of the novel long non-coding RNA LATS2 antisense transcript 1 (LATS2-AS1-001) in gastric cancer (GC). Methods: qRT-PCR was applied to evaluate LATS2-AS1-001 expression and correlation with LATS2 in GC. In vitro experiments were performed to investigate the role of LATS2-AS1-001 in GC cells. RNA immunoprecipitation (RIP) was performed to assess the interaction between EZH2 and LATS2-AS1-001. LATS2/YAP1 signaling pathway proteins were detected by immunoblot. Oncomine and KMPLOT data analysis was conducted to assess the prognostic value of YAP1 in GC. Results: Decreased expression levels of LATS2-AS1-001 and LATS2 were confirmed in 357 GC tissues compared with the normal mucosa. A strong positive correlation between LATS2-AS1-001 and LATS mRNA expression was found in Pearson Correlation analysis (r = 0.719, P < 0.001). Furthermore, ROC curve analysis revealed areas under the curves for LATS2-AS1-001 and LATS2 of 0.7274 and 0.6865, respectively (P < 0.001), which indicated that LATS2-AS1-001 and LATS could be used as diagnostic indicators in GC. Moreover, ectopic expression of LATS2-AS1-001 decreased cell viability, induced G0/G1 phase arrest, and inhibited cell migration and invasion in GC cells. Mechanistically, overexpressing LATS2-AS1-001 upregulated LATS2 and induced YAP1 phosphorylation via binding to EZH2. Oncomine and KMPLOT database analysis demonstrated YAP1 was highly expressed in human GC samples, and high YAP1 expression predicted poor patient prognosis in GC. Conclusion: This study revealed that lncRNA LATS2-AS1-001 might serve as a potential diagnostic index in GC and act as a suppressor of GC progression.Keywords
Funding Information
- National Natural Science Foundation of China (81971584)
- National Natural Science Foundation of China (81071650)
- Special foundation for Science and Technology Program in Liaoning Province, China (2013225585)
- Supporting Project for Climbing Scholars in Liaoning Provincial Universities, China (2009)
This publication has 52 references indexed in Scilit:
- RETRACTED: linc01088 promotes cell proliferation by scaffolding EZH2 and repressing p21 in human non-small cell lung cancerLife Sciences, 2020
- Long non-coding RNA-mediated regulation of signaling pathways in gastric cancerClinical Chemistry and Laboratory Medicine (CCLM), 2018
- The Hippo Pathway: Immunity and CancerCancers, 2018
- Antisense transcription‐dependent chromatin signature modulates sense transcript dynamicsMolecular Systems Biology, 2018
- Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cellsCell Death & Disease, 2016
- Gastric Cancer: How Can We Reduce the Incidence of this Disease?Current Gastroenterology Reports, 2016
- Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancerTumor Biology, 2015
- Trends and results in treatment of gastric cancer over last two decades at single East European centre: a cohort studyBMC Surgery, 2014
- Down-regulation of LATS2 in non-small cell lung cancer promoted the growth and motility of cancer cellsTumor Biology, 2014
- Lats2 Modulates Adipocyte Proliferation and Differentiation via Hippo SignalingPLOS ONE, 2013